Chimerix reported $256.86M in Equity Capital and Reserves for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Ardelyx ARDX:US USD 98.33M 31.47M
Chimerix CMRX:US USD 256.86M 17.1M
Curis CRIS:US USD 46.55M 9.19M
Dynavax Technologies DVAX:US USD 581.01M 80.44M
Emergent Biosolutions EBS:US USD 1.38B 66.3M
Gilead Sciences GILD:US USD 21.21B 128M
Glaxosmithkline GSK:US GBP 10.6B 1.45B
Life Technologies LIFE:US USD 71.28M 5.9M
Mirati Therapeutics MRTX:US USD 996.52M 132.54M
Novavax NVAX:US USD -634078000 68.09M